Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Henan Jindan Lactic Acid Technology Co., Ltd (300829.SZ)
Zhoukou, CN
Henan Jindan Lactic Acid Technology Co., Ltd, founded in 1984 and based in Zhoukou, China, is a prominent manufacturer specializing in the production and distribution of lactic acid and a wide variety of lactate products. The company offers an extensive portfolio that includes lactic acid, calcium lactate, sodium lactate, potassium lactate, ferrous lactate, lactic acid powder, ethyl lactate, magnesium lactate, zinc lactate, buffered lactic acid, as well as specific blends like sodium lactate with sodium di-acetate, and sodium lactate with potassium. While primarily serving the Chinese domestic market, Henan Jindan also has a significant international footprint, exporting its goods to diverse regions including Europe, North America, South America, Oceania, Southeast Asia, and various other global markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.09% | -3.03% | +8.40% | -1.15% | +6.02% | +13.62% | +0.80% | -10.41% | -67.73% | -7.01% | -7.01% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+7.2% ★ Q1'26: +13.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+175.0% ★ Q1'26: -35.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+3.1% Q1'26: -2.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+9.0% ★ Q1'26: +6.9% (vs Q1'25)
-
ROIC Chemicals: +3.4%+4.6% ★ Q1'26: +3.5% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+11.2% Q1'26: +15.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.54× Q1'26: 7.99× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
1.44B
est: 1.56B (-7.6%)
|
1.53B
est: 1.76B (-12.7%)
|
1.42B
est: 1.76B (-19.3%)
|
1.51B
est: 1.60B (-5.9%)
|
1.61B
est: 1.97B (-18.1%)
|
2.83B
2.83B – 2.83B
+43.4% YoY
|
| EBITDA |
229.89M
est: 265.12M (-13.3%)
|
255.94M
est: 298.60M (-14.3%)
|
239.32M
est: 298.60M (-19.9%)
|
179.20M
est: 257.25M (-30.3%)
|
307.35M
est: 317.26M (-3.1%)
|
454.97M
454.97M – 454.97M
+43.4% YoY
|
| EBIT |
140.72M
est: 135.76M (+3.6%)
|
141.22M
est: 152.91M (-7.6%)
|
112.31M
est: 152.91M (-26.5%)
|
49.18M
est: 125.05M (-60.7%)
|
144.56M
est: 154.22M (-6.3%)
|
221.16M
221.16M – 221.16M
+43.4% YoY
|
| Net Income |
129.18M
est: 286.81M (-55.0%)
|
132.23M
est: 119.97M (+10.2%)
|
85.23M
est: 119.97M (-29.0%)
|
37.49M
est: 118.86M (-68.5%)
|
114.69M
est: 168.91M (-32.1%)
|
210.62M
210.62M – 210.62M
+24.7% YoY
|
| SGA |
78.51M
est: 31.41M (+149.9%)
|
87.73M
est: 35.38M (+148.0%)
|
81.45M
est: 35.38M (+130.2%)
|
86.37M
est: 79.30M (+8.9%)
|
34.79M
est: 97.80M (-64.4%)
|
140.25M
140.25M – 140.25M
+43.4% YoY
|
| EPS |
0.72
est: 1.53 (-52.9%)
|
0.73
est: 0.64 (+14.1%)
|
0.47
est: 0.64 (-26.6%)
|
0.20
est: 0.57 (-64.9%)
|
0.55
est: 0.81 (-32.1%)
|
1.01
1.01 – 1.01
+24.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Congliang Shi | GM & Director | — | male |
| Fei Chen | Financial Director | — | male |
| Gui Zhi Liang | Accounting Supervisor | — | — |
| Yaojun Cui | Deputy GM, Board Secretary & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300829.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
